Skip to main content

Table 4 The proportion of treatment modalities (no transplantation vs transplantation) in different cytogenetic category, age group and disease subtypes

From: An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification

  no transplantation transplantation
Cytogenetic category Intermediate, n = 79 68.4% (54/79) 31.6% (25/79)
Unfavorable, n = 11 100% (11/11) 0 (0/11)
Age group <40, n = 54 59.3% (32/54) 40.7% (22/54)
40–60, n = 34 85.3% (29/34) 14.7% (5/34)
>60, n = 9 100% (9/9) 0 (0/9)
Subtypes MDS, n = 65 70.8% (46/65) 29.2% (19/65)
AML, n = 32 75% (24/32) 25% (8/32)